Amicogen Inc (092040) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.012x

Based on the latest financial reports, Amicogen Inc (092040) has a cash flow conversion efficiency ratio of 0.012x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.11 Billion ≈ $749.28K USD) by net assets (₩95.86 Billion ≈ $64.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Amicogen Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Amicogen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Amicogen Inc debt and liabilities for a breakdown of total debt and financial obligations.

Amicogen Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Amicogen Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dreadnought Resources Ltd AU:DRE	-0.014x
Envirosuite Limited F:57P	0.005x
Marchex Inc NASDAQ:MCHX	0.004x
Invesco High Income Trust II NYSE:VLT	0.069x
Feelux Co. Ltd. KO:033180	-0.009x
Export Packing KO:002200	0.002x
Enertork Ltd KQ:019990	-0.015x
NEW ZEALAND RURAL F:8UK	N/A

Annual Cash Flow Conversion Efficiency for Amicogen Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Amicogen Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Amicogen Inc (092040) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩122.50 Billion ≈ $83.01 Million	₩-13.34 Billion ≈ $-9.04 Million	-0.109x	-375.82%
2023-12-31	₩218.97 Billion ≈ $148.40 Million	₩8.64 Billion ≈ $5.86 Million	0.039x	+123.21%
2022-12-31	₩131.80 Billion ≈ $89.32 Million	₩-22.41 Billion ≈ $-15.19 Million	-0.170x	-492.13%
2021-12-31	₩186.16 Billion ≈ $126.16 Million	₩8.07 Billion ≈ $5.47 Million	0.043x	-25.19%
2020-12-31	₩152.94 Billion ≈ $103.65 Million	₩8.87 Billion ≈ $6.01 Million	0.058x	-19.24%
2019-12-31	₩122.05 Billion ≈ $82.71 Million	₩8.76 Billion ≈ $5.94 Million	0.072x	+221.69%
2018-12-31	₩127.28 Billion ≈ $86.26 Million	₩2.84 Billion ≈ $1.92 Million	0.022x	-83.25%
2017-12-31	₩89.19 Billion ≈ $60.44 Million	₩11.88 Billion ≈ $8.05 Million	0.133x	-3.68%
2016-12-31	₩81.54 Billion ≈ $55.26 Million	₩11.28 Billion ≈ $7.64 Million	0.138x	-8.00%
2015-12-31	₩82.10 Billion ≈ $55.64 Million	₩12.34 Billion ≈ $8.36 Million	0.150x	+69.90%
2014-12-31	₩50.02 Billion ≈ $33.90 Million	₩4.43 Billion ≈ $3.00 Million	0.088x	--

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$67.86 Million

₩100.14 Billion KRW

Market Cap Rank

#20691 Global

#1246 in Korea

Share Price

₩1812.00

Change (1 day)

-3.87%

52-Week Range

₩1175.00 - ₩4690.00

All Time High

₩22094.22